Announced Tue, 11 Aug, 2026 · 22:03 IST

New CEO appointed, three independent directors added, weak Q1 results

Ceo Appointed ExternalManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.1%Reaction day
₹39.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-4.5% vs market
Healthcare Service Provider peers, median of 26sector+0.0%-4.1% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 4.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.1+0.4-4.5+0.0-4.1
Next day
-2.6+0.5-3.1+0.4-3.0
2d
+1.0+0.6+0.4-2.4+3.5
3d
+0.4+0.7-0.3-1.6+2.0
4d
-1.8+1.1-2.9-2.3+0.5
5d
-7.1+0.5-7.6-2.3-4.8
1w
-4.6+1.3-5.9-1.4-3.3
15d
+0.8+0.5+0.3-0.9+1.7
1m
-2.8-0.8-2.0-1.2-1.6
2m
-2.6-0.9-1.6-3.8+1.3
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 results with total income of Rs 870.46 lakhs against Rs 891.88 lakhs in Q1 FY26, posting a marginal net profit of Rs 0.28 lakhs and EPS of Rs 0.00. Full year FY26 loss was Rs 111.72 lakhs. Dr Thanigai Vendan Moorrthy was appointed CEO in non-director capacity for five years. Three new independent directors were also appointed and the Audit Committee and Stakeholders Relationship Committee were reconstituted.

Likely market impact

Leadership refresh with new CEO and independent directors may strengthen governance, but near break-even quarterly results show the hospital remains under financial pressure.